¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"floating receptor model"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
antigen binding receptor
Ç׿ø°áÇÕ¼ö¿ëü
antigen receptor
Ç׿ø¼ö¿ëü
adrenergic receptor
¾Æµå·¹³¯¸°¼ö¿ëü
androgen receptor
¾Èµå·Î°Õ¼ö¿ëü
beta-adrenergic receptor kinase
º£Å¸¾Æµå·¹³¯¸°¼ö¿ëüÀλêÈÈ¿¼Ò
cold receptor
³Ã°¢¼ö¿ë±â
complement receptor
º¸Ã¼¼ö¿ëü
corpuscular receptor
¼Òü¼ö¿ëü
cell surface receptor
¼¼Æ÷Ç¥¸é¼ö¿ëü
cholinergic receptor
Äݸ°¼ö¿ëü
distance receptor
¿ø°Ý¼ö¿ë±â
dominant receptor
¿ì¼º¼ö¿ëü
early receptor potential
Á¶±â¼ö¿ëüÀüÀ§, Á¶±â½Ã°¢¼¼Æ÷ÀüÀ§
estrogen receptor
¿¡½ºÆ®·Î°Õ¼ö¿ëü
free receptor
À¯¸®¼ö¿ëü
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
wax model
¹Ð¶ø¸ðÇü
working model
ÀÛ¾÷¸ðÇü
adrenergic receptor
¾Æµå·¹³¯¸°¼ö¿ëü
androgen receptor
¾Èµå·Î°Õ¼ö¿ëü
antigen receptor
Ç׿ø¼ö¿ëü
antigen binding receptor
Ç׿ø°áÇÕ¼ö¿ëü
receptor autoradiography
¼ö¿ëüÀÚ°¡¹æ»ç¼±¼ú
beta-adrenergic receptor kinase
º£Å¸¾Æµå·¹³¯¸°¼º¼ö¿ëüÀλêÈÈ¿¼Ò
receptor binding
¼ö¿ëü°áÇÕ
receptor blocker
¼ö¿ëüÂ÷´ÜÁ¦
cell surface receptor
¼¼Æ÷Ç¥¸é¼ö¿ëü
cholinergic receptor
Äݸ°¼ö¿ëü
cold receptor
³Ã°¢¼ö¿ëü
complement receptor
µµ¿òü¼ö¿ëü, º¸Ã¼¼ö¿ëü
corpuscular receptor
¼Òü¼ö¿ëü
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
receptor
¼ö¿ë±â
receptor amblyopia
¼ö¿ë±â¾à½Ã
receptor assay
¼ö¿ëÃ¼ÃøÁ¤
receptor autoradiography
¼ö¿ëü ÀÚ±â¹æ»ç¼±ÃÔ¿µ¼ú
receptor binding
¼ö¿ëü°áÇÕ
receptor blockade
¼ö¿ëüÂ÷´Ü
receptor blocking agent
¼ö¿ëüÂ÷´Ü<ºÀ¼â>Á¦.
receptor cell
¼ö¿ëü ¼¼Æ÷
receptor destroying enzyme
¼ö¿ëüÆÄ±«È¿¼Ò(¡÷òÎÕý£áÈ).
receptor gradient
¼ö¿ëü°æ»ç.
receptor hypothesis
¼ö¿ëü°¡¼³
receptor imaging
¼ö¿ëü¿µ»ó(È)
receptor organ
¼ö¿ë±â°ü(áôé»Ðïί).
receptor potential
¼ö¿ë±âÀüÀ§.
receptor sensitivity
¼ö¿ëü °¨¼ö¼º
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
sequential model
¼øÂ÷¸ðµ¨.
single major gene(locus) model
´ÜÀÏ ÁÖ¿äÀ¯ÀüÀÚ(À¯ÀüÁÂÀ§) ¸ðµ¨
single target multi-hit model
´ÜÀÏÇ¥Àû´Ù¹ßÀûÁß ¸ðµ¨
social service model
»çȸ¼ºñ½º¸ðµ¨
stress and coping model
½ºÆ®·¹½º¿Í ´ëó(Óßô¥)¸ðµ¨.
symmetry model
´ëĪÇü(Óßöàúþ), ´ëμ³(Óß öàæò).
time dependent relative risk model
½Ã°£ÀÇÁ¸¼º »ó´ëÀ§Çè¸ðµ¨
viscoelastic model
Á¡Åº¼º¸ðÇü.
wave model
ÆÄÇü
wax model
³³(¿ø)Çü(ÕÅê«úþ).
working model
ÀÛ¾÷¸ðÇü(ËöËâËÎÌ´).
working model for bridgework
±³ÀÇÄ¡¿ë ÀÛ¾÷¸ðÇü(ÎéëùöÍéÄíÂåöÙ¼úþ).
acetylcholine receptor
¾Æ¼¼Æ¿Äݸ°¼ö¿ëü
acetylcholine receptor
¾Æ¼¼Æ¿Äݸ° ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
acetylcholine receptor antibody
¾Æ¼¼Æ¿Äݸ°¼ö¿ëüÇ×ü
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½